Liu J - Search Results

1

Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity.

Zhang X, Sun Y, Zhang Y, Fang F, Liu J, Xia Y, Liu Y. Zhang X, et al. Among authors: liu j, liu y. J Cardiovasc Dev Dis. 2022 Oct 29;9(11):372. doi: 10.3390/jcdd9110372. J Cardiovasc Dev Dis. 2022. PMID: 36354771 Free PMC article. Review.

2

Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells.

Liu Y, Ban LY, Su X, Gao S, Liu JW, Cui XN. Liu Y, et al. Mol Med Rep. 2015 Jul;12(1):1598-604. doi: 10.3892/mmr.2015.3552. Epub 2015 Mar 26. Mol Med Rep. 2015. PMID: 25815590

3

Anti-cancer effects of 2-oxoquinoline derivatives on the HCT116 and LoVo human colon cancer cell lines.

Fang FQ, Guo HS, Zhang J, Ban LY, Liu JW, Yu PY. Fang FQ, et al. Among authors: liu jw. Mol Med Rep. 2015 Dec;12(6):8062-70. doi: 10.3892/mmr.2015.4451. Epub 2015 Oct 16. Mol Med Rep. 2015. PMID: 26498992

4

Emergence, Development, and Future of Cardio-Oncology in China.

Liu Y, Zhang YL, Liu JW, Fang FQ, Li JM, Xia YL. Liu Y, et al. Chin Med J (Engl). 2018 Nov 5;131(21):2640-2644. doi: 10.4103/0366-6999.244101. Chin Med J (Engl). 2018. PMID: 30381608 Free PMC article. No abstract available.

5

Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.

Wang Y, Lv H, Li D, Chen C, Gu G, Sun Y, Yang X, Liu Y, Fang F, Liu J, Tse G, Xia Y. Wang Y, et al. Among authors: liu j, liu y. Front Pharmacol. 2019 Jul 10;10:773. doi: 10.3389/fphar.2019.00773. eCollection 2019. Front Pharmacol. 2019. PMID: 31354488 Free PMC article.

6

Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities.

Liu F, Hidru TH, Gao R, Lin Y, Liu Y, Fang F, Liu J, Li H, Yang X, Xia Y. Liu F, et al. Among authors: liu j, liu y. J Hypertens. 2020 Mar;38(3):426-433. doi: 10.1097/HJH.0000000000002277. J Hypertens. 2020. PMID: 31584518 Free PMC article.

7

Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study.

Zhang Z, Fu X, Liu J, Huang Z, Liu N, Fang F, Rao J. Zhang Z, et al. Among authors: liu j, liu n. Acta Cytol. 2021;65(4):335-341. doi: 10.1159/000510474. Epub 2020 Oct 6. Acta Cytol. 2021. PMID: 33022673

8

PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines.

Safi M, Ahmed H, Al-Azab M, Xia YL, Shan X, Al-Radhi M, Al-Danakh A, Shopit A, Liu J. Safi M, et al. Among authors: liu j. J Adv Res. 2020 Oct 3;29:45-54. doi: 10.1016/j.jare.2020.09.006. eCollection 2021 Mar. J Adv Res. 2020. PMID: 33842004 Free PMC article. Review.

9

Working Together to Advance Cardio-Oncology in China.

Xia Y, Liu J. Xia Y, et al. Among authors: liu j. JACC CardioOncol. 2020 Mar 17;2(1):144-145. doi: 10.1016/j.jaccao.2020.02.008. eCollection 2020 Mar. JACC CardioOncol. 2020. PMID: 34396222 Free PMC article. No abstract available.

10

A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.

Sun R, Ning Z, Qin H, Zhang W, Teng Y, Jin C, Liu J, Wang A. Sun R, et al. Among authors: liu j. Sci Rep. 2024 Apr 25;14(1):9552. doi: 10.1038/s41598-024-55829-5. Sci Rep. 2024. PMID: 38664423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135,949 results

Search Page